Global inequity of COVID-19 diagnostics: challenges and opportunities

Collaborators, Affiliations

COVID-19 Clinical Research Coalition, Virology, Immunology, and Diagnostics Working Group:
Ayouba Ahidjo, Derseree Archary, Dharshan de Silva, Shymaa Enany, Sophia Kitui, Blandina Mmbaga, Wolfgang Preiser, Paramdeep Singh, Aida Sivro, Misaki Wayengera

¹ Division of of Infectious Diseases, Department of Medicine, Duke University, Durham, North Carolina, USA shanti.narayanasamy@duke.edu.
² Hubert-Yeargan Center for Global Health, Duke University, Durham, North Carolina, USA.
³ COVID-19 Clinical Research Coalition, Drugs for Neglected Diseases initiative, Geneva, Switzerland.
⁴ Division of Infection and Global Health, School of Medicine, University of St Andrews, St Andrews, UK.
⁵ Makerere University Lung Institute, Makerere University College of Health Sciences, Kampala, Uganda.
⁶ Department of Pathology, Moi University, Eldoret, Kenya.
⁷ Department of Biomedical Sciences, University of Health and Allied Sciences, Ho, Ghana.
⁸ EHA Clinics, Kano, Nigeria.
⁹ Duke Global Health Institute, Durham, North Carolina, USA.
¹⁰ Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Rondebosch, South Africa.
¹¹ Department of Medicine, University of Cape Town, Rondebosch, South Africa.
¹² Division of of Infectious Diseases, Department of Medicine, Duke University, Durham, North Carolina, USA.

Shanti Narayanasamy et al. J Epidemiol Community Health. 2022.

. 2022 Oct 6:jech-2022-219333.

doi: 10.1136/jech-2022-219333. Online ahead of print.

COVID-19 Clinical Research Coalition, Virology, Immunology, and Diagnostics Working Group:
Ayouba Ahidjo, Derseree Archary, Dharshan de Silva, Shymaa Enany, Sophia Kitui, Blandina Mmbaga, Wolfgang Preiser, Paramdeep Singh, Aida Sivro, Misaki Wayengera

¹ Division of of Infectious Diseases, Department of Medicine, Duke University, Durham, North Carolina, USA shanti.narayanasamy@duke.edu.
² Hubert-Yeargan Center for Global Health, Duke University, Durham, North Carolina, USA.
³ COVID-19 Clinical Research Coalition, Drugs for Neglected Diseases initiative, Geneva, Switzerland.
⁴ Division of Infection and Global Health, School of Medicine, University of St Andrews, St Andrews, UK.
⁵ Makerere University Lung Institute, Makerere University College of Health Sciences, Kampala, Uganda.
⁶ Department of Pathology, Moi University, Eldoret, Kenya.
⁷ Department of Biomedical Sciences, University of Health and Allied Sciences, Ho, Ghana.
⁸ EHA Clinics, Kano, Nigeria.
⁹ Duke Global Health Institute, Durham, North Carolina, USA.
¹⁰ Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Rondebosch, South Africa.
¹¹ Department of Medicine, University of Cape Town, Rondebosch, South Africa.
¹² Division of of Infectious Diseases, Department of Medicine, Duke University, Durham, North Carolina, USA.

No abstract available

Keywords: COVID-19; DIAGNOSTIC TECHNIQUES AND PROCEDURES; HEALTHCARE DISPARITIES.

Conflict of interest statement

Competing interests: None declared.